MTOR and glioblastoma: The blood brain barrier penetrant compound riluzole demonstrated significant inhibition of IRES activity and synergistic anti-GBM affects with mTOR inhibitors as observed for the previously SAR-derived hnRNP A1 inhibitor IRES-J007.